274 related articles for article (PubMed ID: 16718515)
21. A gene therapy/targeted radiotherapy strategy for radiation cell kill by.
Boyd M; Mairs RJ; Cunningham SH; Mairs SC; McCluskey A; Livingstone A; Stevenson K; Brown MM; Wilson L; Carlin S; Wheldon TE
J Gene Med; 2001; 3(2):165-72. PubMed ID: 11318115
[TBL] [Abstract][Full Text] [Related]
22. Arrhenius relationships from the molecule and cell to the clinic.
Dewey WC
Int J Hyperthermia; 2009 Feb; 25(1):3-20. PubMed ID: 19219695
[TBL] [Abstract][Full Text] [Related]
23. Effects of methylxanthines on cell-cycle redistribution and sensitization to killing by low-dose-rate radiation.
Dillehay LE; Chang G; Williams JR
NCI Monogr; 1988; (6):173-6. PubMed ID: 2451134
[TBL] [Abstract][Full Text] [Related]
24. Basic characterization of 64Cu-ATSM as a radiotherapy agent.
Obata A; Kasamatsu S; Lewis JS; Furukawa T; Takamatsu S; Toyohara J; Asai T; Welch MJ; Adams SG; Saji H; Yonekura Y; Fujibayashi Y
Nucl Med Biol; 2005 Jan; 32(1):21-8. PubMed ID: 15691658
[TBL] [Abstract][Full Text] [Related]
25. Radiobiological responses for two cell lines following continuous low dose-rate (CLDR) and pulsed dose rate (PDR) brachytherapy.
Hanisch PH; Furre T; Olsen DR; Pettersen EO
Acta Oncol; 2007; 46(5):602-11. PubMed ID: 17562436
[TBL] [Abstract][Full Text] [Related]
26. 123I-ITdU-mediated nanoirradiation of DNA efficiently induces cell kill in HL60 leukemia cells and in doxorubicin-, beta-, or gamma-radiation-resistant cell lines.
Reske SN; Deisenhofer S; Glatting G; Zlatopolskiy BD; Morgenroth A; Vogg AT; Buck AK; Friesen C
J Nucl Med; 2007 Jun; 48(6):1000-7. PubMed ID: 17504875
[TBL] [Abstract][Full Text] [Related]
27. Low doses of very low-dose-rate low-LET radiation suppress radiation-induced neoplastic transformation in vitro and induce an adaptive response.
Elmore E; Lao XY; Kapadia R; Giedzinski E; Limoli C; Redpath JL
Radiat Res; 2008 Mar; 169(3):311-8. PubMed ID: 18302492
[TBL] [Abstract][Full Text] [Related]
28. [Dose dependent effects of the combined beta-gamma-emitter 188Rhenium on the growth of human vessel wall cells].
Henning E; Dittmann H; Wiskirchen J; Bantleon R; Kehlbach R; Claussen CD; Duda SH
Rofo; 2004 Mar; 176(3):404-8. PubMed ID: 15026955
[TBL] [Abstract][Full Text] [Related]
29. Effect of treatment schedule on the interaction of Cisplatin and radiation in human lung cancer cells.
Asaka-Amano Y; Takiguchi Y; Yatomi M; Kurosu K; Kasahara Y; Tanabe N; Tatsumi K; Kuriyama T
Radiat Res; 2007 Jun; 167(6):637-44. PubMed ID: 17523845
[TBL] [Abstract][Full Text] [Related]
30. Cell death induced by 131 I in a differentiated thyroid carcinoma cell line in vitro: necrosis or apoptosis?
Marx K; Moka D; Schomäcker K; Fischer T; Gabruk-Szostak B; Kobe C; Dietlein M; Schicha H
Nucl Med Commun; 2006 Apr; 27(4):353-8. PubMed ID: 16531921
[TBL] [Abstract][Full Text] [Related]
31. Recovery from sublethal damage during fractionated irradiation of human FaDu SCC.
Petersen C; Zips D; Krause M; Völkel W; Thames HD; Baumann M
Radiother Oncol; 2005 Mar; 74(3):331-6. PubMed ID: 15763315
[TBL] [Abstract][Full Text] [Related]
32. Radiation administered as a large single dose or in a fractionated schedule: Role of the tumour vasculature as a target for influencing response.
Horsman MR; Nielsen T; Østergaard L; Overgaard J
Acta Oncol; 2006; 45(7):876-80. PubMed ID: 16982553
[TBL] [Abstract][Full Text] [Related]
33. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
34. Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy.
Onimaru R; Fujino M; Yamazaki K; Onodera Y; Taguchi H; Katoh N; Hommura F; Oizumi S; Nishimura M; Shirato H
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):374-81. PubMed ID: 18029106
[TBL] [Abstract][Full Text] [Related]
35. A low-dose hypersensitive keratinocyte loss in response to fractionated radiotherapy is associated with growth arrest and apoptosis.
Turesson I; Nyman J; Qvarnström F; Simonsson M; Book M; Hermansson I; Sigurdardottir S; Johansson KA
Radiother Oncol; 2010 Jan; 94(1):90-101. PubMed ID: 19931928
[TBL] [Abstract][Full Text] [Related]
36. In vitro cytotoxicity of low-dose-rate radioimmunotherapy by the alpha-emitting radioimmunoconjugate Thorium-227-DOTA-rituximab.
Dahle J; Krogh C; Melhus KB; Borrebaek J; Larsen RH; Kvinnsland Y
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):886-95. PubMed ID: 19679402
[TBL] [Abstract][Full Text] [Related]
37. Reduced iodide transport (stunning) and DNA synthesis in thyrocytes exposed to low absorbed doses from 131I in vitro.
Lundh C; Nordén MM; Nilsson M; Forssell-Aronsson E
J Nucl Med; 2007 Mar; 48(3):481-6. PubMed ID: 17332627
[TBL] [Abstract][Full Text] [Related]
38. The impact of conventional and heavy ion irradiation on tumor cell migration in vitro.
Goetze K; Scholz M; Taucher-Scholz G; Mueller-Klieser W
Int J Radiat Biol; 2007; 83(11-12):889-96. PubMed ID: 18058372
[TBL] [Abstract][Full Text] [Related]
39. A theoretical investigation into post-operative, intracavitary beta therapy of high-grade glioblastomas using yttrium-90.
Stefanou SS; Sparks RB; Dale RG
Phys Med Biol; 2006 Oct; 51(20):5377-89. PubMed ID: 17019045
[TBL] [Abstract][Full Text] [Related]
40. Single-cell-based computer simulation of the oxygen-dependent tumour response to irradiation.
Harting C; Peschke P; Borkenstein K; Karger CP
Phys Med Biol; 2007 Aug; 52(16):4775-89. PubMed ID: 17671335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
